Screening and Characterization of Drugs That Protect Corneal Endothelial Cells Against Unfolded Protein Response and Oxidative Stress.

Invest Ophthalmol Vis Sci · 2017 · PMC5295784 · PMID 28159976

Europe PMC DOI

hedged sentence

0.2300

closest p · 4.6× alpha

0.2300

boldest claim

The sentences

showed a trendP = 0.23not close (p > 0.1)

14 , 15 For thapsigargin-exposed iHCECs, oxotremorine treatment showed a trend for reduced ATF4 mRNA expression to 118.2 ± 43.7% ( P = 0.23) compared with untreated controls (148.3 ± 28.3%) and reduced CHOP mRNA expression to 112.3 ± 60.6% ( P = 0.024) compared with untreated controls (188.1 ± 8.0%; Fig. 7 A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.